{"meshTagsMajor":["Mass Screening","Prostatic Neoplasms"],"meshTags":["Aged","Physical Examination","Predictive Value of Tests","Mass Screening","United States","Cost-Benefit Analysis","Prostatic Neoplasms","Humans","Middle Aged","Male","Prostate-Specific Antigen"],"meshMinor":["Aged","Physical Examination","Predictive Value of Tests","United States","Cost-Benefit Analysis","Humans","Middle Aged","Male","Prostate-Specific Antigen"],"publicationTypes":["Journal Article","Review"],"title":"Prostate cancer, screening, and prostate-specific antigen: promise or peril?","pubmedId":"7525903"}